Conditional Reprogramming: A Living Biomarker and Phenotypic Screening Drug Platform for Urological Cancer
Danyal Daneshdoust(The Ohio State University), Xuefeng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zaibo Li(The Ohio State University Wexner Medical Center), Cheryl Lee(Agency for Science, Technology and Research), Qi‐En Wang(Emory University), Anil V. Parwani(The Ohio State University Wexner Medical Center), Abdul Qawee Rani, Shang-Jui Wang(The Ohio State University Wexner Medical Center), Peng Wang(The Ohio State University Wexner Medical Center), Nagireddy Putluri(Baylor College of Medicine), Jenny Li(The Ohio State University), Debasish Sundi(The Ohio State University)
Cited by 0
Related Papers
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
|American Journal Of Pathology|2011|738
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
|Cell Reports|2016|320
What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast
|Stem Cell Reports|2016|308
Standardization of Radical Cystectomy and Pelvic Lymph Node Dissection for Bladder Cancer: A Collaborative Group Report
|The Journal of Urology|2004|293